The F-CP level was also lower in the MSC-treated patients with T2DM than in the controls, and its level increased significantly from baseline, in the MSC-treated group after follow-up (SMD = 0.62, 95% CI 0.21 to 1.03, P = 0.003; Fig. 8). Here, CP is linked to type 2 diabetes mellitus.